Prenatal diagnosis and genetic counseling of a Chinese Alport syndrome kindred

Genetic Testing

Volumn 12, Issue 1, 2008, Pages 1-7

  Zhang, Hongwen ^a   Ding, Jie ^a   Wang, Fang ^a   Yang, Huixia ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA;

ADULT; ALPORT SYNDROME; AMINO ACID SEQUENCE; AMNION CELL; ARTICLE; CHINESE; CLINICAL ARTICLE; COL4A5 GENE; CONTROLLED STUDY; FEMALE; FETUS; GENE; GENE AMPLIFICATION; GENE MUTATION; GENETIC COUNSELING; GENETIC LINKAGE; GENETIC VARIABILITY; HUMAN; KARYOTYPING; LINKAGE ANALYSIS; MALE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; PRESCHOOL CHILD; SRY GENE; X CHROMOSOME LINKED DISORDER;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CHINA; CHROMOSOMES, HUMAN, X; COLLAGEN TYPE IV; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HUMANS; INFANT, NEWBORN; MALE; MUTATION, MISSENSE; NEPHRITIS, HEREDITARY; PEDIGREE; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; RNA, MESSENGER; SEX DETERMINATION (ANALYSIS);

EID: 41449094303     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.2007.0026     Document Type: Article

References (27)

1. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW (1992) Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 51:1229-1239.
2. Antoniadi T, Yapijakis C, Kaminopetros P, Makatsoris C, Velissariou V, Vassilopoulos D, Petersen MB (2002) A simple and effective approach for detecting maternal cell contamination in molecular prenatal diagnosis. Prenat Diagn 22:425-429.
3. Barker DF, Denison JC, Atkin CL, Gregory MC (2001) Efficient detection of Alport syndrome COL4A5 mutations with multiplex genomic PCR-SSCP. Am J Med Genet 98:148-160.
4. Batanian JR, Ledbetter DH, Fenwick RG (1998) A simple VNTR-PCR method for detecting maternal cell contamination in prenatal diagnosis. Genet Test 2:347-350.
5. Canadian Collaborative CVS-Amniocentesis Clinical Trial Group (1989) Multicentre randomised clinical trial of chorion villus sampling and amniocentesis. First report. Lancet 1:1-6.
6. Charytan D, Torre A, Khurana M, Nicastri A, Stillman IE, Kalluri R (2004) Allograft rejection and glomerular basement membrane antibodies in Alport's syndrome. J Nephrol 17:431-435.
7. Copelovitch L, Kaplan BS (2006) Is genetic testing of healthy presymptomatic children with possible Alport syndrome ethical? Pediatr Nephrol 21:455-456.
8. Golshayan D, Venetz JP, Cachat F, Fellmann F, Moll S, Burnier M, Barbey F (2006) [Clinical and genetic aspects of Alport syndrome]. Rev Med Suisse 2:593-598.
9. Heidet L, Arrondel C, Forestier L, Cohen-Solal L, Mollet G, Gutierrez B, Stavrou C, Gubler MC, Antignac C (2001) Structure of the human type IV collagen gene COL4A3 and mutations in autosomal Alport syndrome. J Am Soc Nephrol 12:97-106.
10. Hertz JM, Heiskari N, Zhou J, Jensen UB, Tryggvason K (1995) A nonsense mutation in the COL4A5 collagen gene in a family with X-linked juvenile Alport syndrome. Kidney Int 47:327-332.
11. Kashtan CE (1997) Alport syndrome. Kidney Int Suppl 58:S69-S71.
12. King K, Flinter FA, Nihalani V, Green PM (2002) Unusual deep intronic mutations in the COL4A5 gene cause X linked Alport syndrome. Hum Genet 111:548-554.
13. Levy M, Pirson Y, Simon P, Boudailliez B, Nivet H, Rance N, Moynot A, Broyer M, Grunfeld JP (1994) Evaluation in patients with Alport syndrome of knowledge of the disease and attitudes toward prenatal diagnosis. Clin Nephrol 42:211-220.
14. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS (1997) Presence of fetal DNA in maternal plasma and serum. Lancet 350:485-487.
15. Longo I, Porcedda P, Mari F, Giachino D, Meloni I, Deplano C, Brusco A, Bosio M, Massella L, Lavoratti G, Roccatello D, Frasca G, Mazzucco G, Muda AO, Conti M, Fasciolo F, Arrondel C, Heidet L, Renieri A, de Marchi M (2002) COL4A3/ COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome. Kidney Int 61:1947-1956.
16. Martin P, Heiskari N, Zhou J, Leinonen A, Tumelius T, Hertz JM, Barker D, Gregory M, Atkin C, Styrkarsdottir U, Neumann H, Springate J, Shows T, Pettersson E, Tryggvason K (1998) High mutation detection rate in the COL4A5 collagen gene in suspected Alport syndrome using PCR and direct DNA sequencing. J Am Soc Nephrol 9:2291-2301.
17. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
18. Nagel M, Nagorka S, Gross O (2005) Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome. Hum Mutat 26:60.
19. Pajari H, Koskimies O, Muhonen T, Kaariainen H (1999) The burden of genetic disease and attitudes towards gene testing in Alport syndrome. Pediatr Nephrol 13:471-476.
20. Pajari H, Sinkkonen J (2000) Psychosocial impact of an X-linked hereditary disease: a study of Alport syndrome patients and family members. Child Care Health Dev 26:239-250.
21. Plant KE, Green PM, Vetrie D, Flinter FA (1999) Detection of mutations in COL4A5 in patients with Alport syndrome. Hum Mutat 13:124-132.
22. Prakash S, Chung KW, Sinha S, Barmada M, Ellis D, Ferrell RE, Finegold DN, Randhawa PS, Dinda A, Vats A (2003) Autosomal dominant progressive nephropathy with deafness: linkage to a new locus on chromosome 11q24. J Am Soc Nephrol 14:1794-1803.
23. Steed HL, Tomkins DJ, Wilson DR, Okun N, Mayes DC (2002) Maternal cell contamination of amniotic fluid samples obtained by open needle versus trocar technique of amniocentesis. J Obstet Gynaecol Can 24:233-236.
24. Steinberg S, Katsanis S, Moser A, Cutting G (2005) Biochemical analysis of cultured chorionic villi for the prenatal diagnosis of peroxisomal disorders: biochemical thresholds and molecular sensitivity for maternal cell contamination detection. J Med Genet 42:38-44.
25. Stojilkovic-Mikic T, Mann K, Docherty Z, Mackie Ogilvie C (2005) Maternal cell contamination of prenatal samples assessed by QF-PCR genotyping. Prenat Diagn 25:79-83.
26. Turco AE, Bresin E, Rossetti S, Peterlin B, Morandi R, Pignatti PF (1997) Rapid DNA-based prenatal diagnosis by genetic linkage in three families with Alport's syndrome. Am J Kidney Dis 30:174-179.
27. Wang F, Wang Y, Ding J, Yang J (2005) Detection of mutations in the COL4A5 gene by analyzing cDNA of skin fibroblasts. Kidney Int 67:1268-1274.